60 Degrees Pharmaceuticals, Inc.
SXTP
$1.63
-$0.08-4.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -40.14% | 71.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -40.14% | 71.68% | |||
| Cost of Revenue | -77.55% | 79.29% | |||
| Gross Profit | 2,250.55% | -215.19% | |||
| SG&A Expenses | -2.15% | -6.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.74% | 49.22% | |||
| Operating Income | 17.55% | -44.91% | |||
| Income Before Tax | 37.81% | -33.66% | |||
| Income Tax Expenses | -700.00% | -80.00% | |||
| Earnings from Continuing Operations | 37.89% | -33.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -28.57% | -41.67% | |||
| Net Income | 37.89% | -33.60% | |||
| EBIT | 17.55% | -44.91% | |||
| EBITDA | 17.76% | -45.26% | |||
| EPS Basic | 44.77% | 47.35% | |||
| Normalized Basic EPS | 46.41% | 46.41% | |||
| EPS Diluted | 44.77% | 47.35% | |||
| Normalized Diluted EPS | 46.41% | 46.41% | |||
| Average Basic Shares Outstanding | 16.04% | 149.57% | |||
| Average Diluted Shares Outstanding | 16.04% | 149.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||